Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.

Fareed, K R

Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. [electronic resource] - British journal of cancer May 2010 - 1600-7 p. digital

Publication Type: Evaluation Study; Journal Article

1532-1827

10.1038/sj.bjc.6605686 doi


Adenocarcinoma--diagnosis
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Pharmacological--analysis
Biomarkers, Tumor--metabolism
Cell Nucleus--metabolism
Cell Proliferation
DNA-Binding Proteins--metabolism
Endonucleases--metabolism
Esophageal Neoplasms--diagnosis
Female
Humans
Male
Middle Aged
Neoadjuvant Therapy
Platinum Compounds--administration & dosage
Prognosis
Stomach Neoplasms--diagnosis
Survival Analysis
Tissue Array Analysis
Treatment Outcome
Tumor Burden--physiology